Heart Failure in the Frail Elderly

  • George A. Heckman
  • Robert S. McKelvie
  • Irene D. Turpie
Chapter
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 250)

Abstract

Heart Failure (HF) is the only major cardiovascular syndrome that is increasing in prevalence in developed countries. In addition to the longer survival of patients with ischemic heart disease and hypertension, the primary reason for this increase is population aging <[Coats, 1998]; [Rich, 2001]>. The greatest proportional growth is occurring among persons over 80 years of age, in whom the prevalence of HF is highest <US Census, 1996; [AHA, 2002]>. As a result, while the number of adults over the age of 65 will double by 2030, the overall prevalence of HF is expected to quadruple. In addition to its substantial morbidity and mortality, HF imposes a significant financial burden <[O’Connell etal, 1994]>.

Keywords

Placebo Toxicity Pneumonia Dementia Angiotensin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adams KF, Gheorghiade M, Uretsky BF, Patterson JH, Schwartz TA, Young JB. J Am Coll Cardiol 2002; 39:946–953.Google Scholar
  2. 2.
    Advisory Council to Improve Outcomes Nationwide in Heart Failure. Consensus recommendations for the management of chronic heart failure. Am J Cardiol 1999; 83(2A).Google Scholar
  3. 3.
    American Heart Association. Heart disease and stroke statistics - 2003 update. Dallas, Tex.: American Heart Association 2002.Google Scholar
  4. 4.
    Ahmed A, Allman RM, DeLong JF, Bodner EV, Howard G. Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients. South Med J 2002; 95:703–710.PubMedGoogle Scholar
  5. 5.
    Ahmed A, Weaver MT, Allman RM, DeLong JF, Aronow WS. Quality of care of nursing home residents hospitalized with heart failure. J Am Geriatr Soc 2002; 50:1831–1836.PubMedGoogle Scholar
  6. 6.
    Ahmed A, Allman RM, Delong JF, Bodner EV, Howard G. Age-related underutilization of left-ventricular function evaluation in older heart failure patients. South Med J 2002; 95:695–702.PubMedGoogle Scholar
  7. 7.
    Ahmed A, Kiefe Cl, Allman RM, Sims RV, DeLong JF. Survival benefits of angiotensin- converting enzyme inhibitors in older heart failure patients with perceived contraindications. J Am Geriatr Soc 2002;50:1659–1666.PubMedGoogle Scholar
  8. 8.
    Almeida OP, Tamai S. Congestive heart failure and cognitive functioning amongst older adults. Arq Neuropsiquiatr 2001; 59(2-B):324–329.PubMedGoogle Scholar
  9. 9.
    Almeida OP, Flicker L. The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning. Intern Med J 2001; 31:290–295.PubMedGoogle Scholar
  10. 10.
    Almeida OP, Tamai S. Clinical treatment reverses attentional deficits in congestive heart failure. BMC Geriatr 2001; 1:2.PubMedGoogle Scholar
  11. 11.
    Anderson MA, Pena RA, Helms LB. Home care utilization by congestive heart failure patients: a pilot study. Public Health Nursing 1998; 15:146–162.PubMedGoogle Scholar
  12. 12.
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4thEd, Text Revision. Washington DC, American Psychiatric Association, 2000.Google Scholar
  13. 13.
    Arling ML. Management of heart failure in nursing facility residents according to AMDA guidelines. Nurs Home Med 1997; 5:374–380.Google Scholar
  14. 14.
    Arling ML. Outcomes of ACE inhibitor use in nursing facility residents with congestive heart failure. Ann Long Term Care 1998; 6:237–241.Google Scholar
  15. 15.
    Aronow WS, Ahn C, Kronzon I. Normal left ventricular ejection fraction in older persons with congestive heart failure. Chest 1998; 113:867–869.PubMedGoogle Scholar
  16. 16.
    Batchelor WB, Anstrom KJ, Muhlbaier LH, Grosswald R, Weintraub S, 0=Neill WW, Peterson ED. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7472 octogenarian. J Am Coll Cardiol 2000; 36:723–730.PubMedGoogle Scholar
  17. 17.
    Beller GA, Smith TW, Abelmann WH, Haber E, Hood Jr WB. Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med 1971; 284:989–987.PubMedGoogle Scholar
  18. 18.
    Blackman DJ, Ferguson JD, Sprigings DC, Banning AP. Revascularization for acute coronary syndromes in older people. Age Ageing 2003; 32:129–35.PubMedGoogle Scholar
  19. 19.
    Bowman CE, Elford J, Dovey J, Campbell S, Barrowclough H. Acute hospital admissions from nursing homes: some may be avoidable. Postgrad Med J 2001; 77:40–42.PubMedGoogle Scholar
  20. 20.
    Burns RB, McCarthy EP, Moskowitz MA, Ash A, Kane RL, Finch M. Outcomes for older men and women with congestive heart failure. J Am Geriatr Soc 1997; 45:276–280.PubMedGoogle Scholar
  21. 21.
    Cacciatore F, Abete P, Ferrara N, Calabrese C, Napoli C, Maggi S, Varrichio M, Rengo F. Congestive heart failure and cognitive impairment in an older population. J Am Geriatr Soc 1998; 46:1343–1348.PubMedGoogle Scholar
  22. 22.
    Chen Y-T, Wang Y, Radford MJ, Krumholz HM. Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure. Am Heart J 2001; 141:410–417.PubMedGoogle Scholar
  23. 23.
    Chin MH, Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health 1997; 87:643–648.PubMedGoogle Scholar
  24. 24.
    Chin MH, Wang JC, Zhang JX, Sachs GA, Lang RM. Differences among geriatricians, general internists, and cardiologists in the care of patients with heart failure: a cautionary tale of quality assessment. J Am Geriatr Soc 1998; 46:1349–1354.PubMedGoogle Scholar
  25. 25.
    Cleland JG, Tendera M, Adamus J, Freemantle N, Gray CS, Lye M, 0=Mahony D, Polonski L, Taylor J. Perindopril for elderly people with chronic heart failure: the PEP-HF study. Eur J Heart Failure 1999; 1:211–217.Google Scholar
  26. 26.
    Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, van Gilst WH, Hobbs FD, Korewicki J, Madeira HC, Preda I, Swedberg K, Widimsky J. Management of heart failure in primary care (the IMPROVEMENT of heart failure programme): an international study. Lancet 2002; 360:1631–1639.PubMedGoogle Scholar
  27. 27.
    Coats A JS. Is preventive medicine responsible for the increasing prevalence of heart failure? Lancet 1998; 352(suppl 1):39–41.Google Scholar
  28. 28.
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31–41.PubMedGoogle Scholar
  29. 29.
    Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001; 345:1667–1675.PubMedGoogle Scholar
  30. 30.
    Croft JB, Giles WH, Pollard RA, Casper ML, Anda RF, Livengood JR. National trends in the initial hospitalization for heart failure. J Am Geriatr Soc 1997; 45:270–275.PubMedGoogle Scholar
  31. 31.
    Croft JB, Giles WH, Pollard RA, Keenan NL, Casper ML, Anda RF. Heart failure survival among older adults in the United States. Arch Intern Med 1999; 159:505–510.PubMedGoogle Scholar
  32. 32.
    Davies MK, Hobbs FDR, Davis RC, Kenkre JE, Roalfe AK, Hare R, Wosornu D, Lancashire RJ. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiography Heart of England Screening study: a population based study. Lancet 2001; 358:439–444.PubMedGoogle Scholar
  33. 33.
    Devereaux PJ, Anderson DR, Gardner MJ, Putnam W, Flowerdew GJ, Brownell BF, Nagpal S, Cox JL. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ 2001; 323:1218–1222.PubMedGoogle Scholar
  34. 34.
    The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336:525–533.Google Scholar
  35. 35.
    Ekman I, Fagerberg B, Skoog I. The clinical implications of cognitive impairment in elderly patients with chronic heart failure. J Cardiovasc Nurs 2001; 16:47–55.PubMedGoogle Scholar
  36. 36.
    Fagerberg B and the MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353:2001–2007.Google Scholar
  37. 37.
    Ferruci L, Guralnik JM, Pahor M, Corti MC, Havlik RJ. Hospital diagnoses, medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA 1997; 277:728–734.Google Scholar
  38. 38.
    Forman DE, Chander RB, Lapane KL, Shah P, Stoukides J. Evaluating the use of angiotensin-converting enzyme inhibitors for older nursing home residents with chronic heart failure. J Am Geriatr Soc 1998; 46:1550–1554.PubMedGoogle Scholar
  39. 39.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA. Frailty in older adults: evidence for a phenotype. J Gerontol Med Sci 2001; 56A:M146-M156.Google Scholar
  40. 40.
    Friesinger II GC, Butler J. End-of-life care for elderly patients with heart failure. Clin Geriatric Med 2000; 16:663–675.Google Scholar
  41. 41.
    Fuat A, Hungin APS, Murphy JJ. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 2003; 326:196–201.PubMedGoogle Scholar
  42. 42.
    Fujikawa K, Kasahara M, Matsui Y, Takeuchi H. Human atrial natriuretic peptide is a useful criterion in treatment of nocturia. Scand J Urol Nephrol 2001; 35:310–313.PubMedGoogle Scholar
  43. 43.
    Gambassi G, Forman DE, Lapane KL, Mor V, Sgadari A, Lipsitz LA, Bernabei R. Management of heart failure among very old persons living in long-term care: Has the voice of trials spread? Am Heart J 2000; 139:85–93.PubMedGoogle Scholar
  44. 44.
    Gambassi G, Lapane KL, Sgadari A, Carbonin P, Gatsonis C, Lipsitz LA, Mor V, Bernabei R. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. Arch Intern Med 2000; 160:53–60.PubMedGoogle Scholar
  45. 45.
    Ganz DA, Lamas GA, Orav EJ, Goldman L, Gutierrez PR, Mangione CM. Age-related differences in management of heart disease: a study of cardiac medication use in an older cohort. J Am Geriatr Soc 1999; 47:145–150.PubMedGoogle Scholar
  46. 46.
    Garg A, Yusuf S. Overview of randomized trials of angiotensin converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273:1450.PubMedGoogle Scholar
  47. 47.
    Georgiadis D, Sievert M, Cencetti S, Uhlmann F, Krivokuca M, Zierz S, Werden K. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J 2000; 21:407–413.PubMedGoogle Scholar
  48. 48.
    Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Arch Intern Med 1988; 148:2013–2016.PubMedGoogle Scholar
  49. 49.
    Gibbs JSR, McCoy ASM, Gibbs LME, Rogers AE, Addington-Hall JM. Living with and dying from heart failure: the role of palliative care. Heart 2002; 88(Suppl II):ii36-ii39.PubMedGoogle Scholar
  50. 50.
    Gillum RF. Epidemiology of heart failure in the United States. Am Heart J 1993; 126:1042–1047.PubMedGoogle Scholar
  51. 51.
    Gooding J, Jette AM. Hospital readmissions among the elderly. J Am Geriatr Soc 1985; 33:595–601.PubMedGoogle Scholar
  52. 52.
    Gross JS, Neufeld RR, Libow LS, Gerber I, Rodstein M. Autopsy study of the elderly institutionalized patient: Review of 234 autopsies. Arch Intern Med 1988; 148:173–176.Google Scholar
  53. 53.
    Grubb NR, Simpson C, Fox KAA. Memory function in patients with stable, moderate to severe cardiac failure. Am Heart J 2000; 140:1–5.Google Scholar
  54. 54.
    Haas GJ, Young JB. Inappropriate use of digoxin in the elderly. Drug Safety 1999; 20:223–230.PubMedGoogle Scholar
  55. 55.
    Haldeman GA, Croft JB, Giles WH, Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 1999; 137:352–360.PubMedGoogle Scholar
  56. 56.
    Hanratty CG, McGlinchey P, Johnston GD, Passmore AP. Differential pharmacokinetics of digoxin in elderly patients. Drugs Aging 2000; 17:353–362.PubMedGoogle Scholar
  57. 57.
    Hanratty B, Hibbert D, Mair F, May C, Ward C, Capewell S, Litva A, Corcoran G. Doctors' perceptions of palliative care for heart failure: focus group study. BMJ 2002; 325:581–585.PubMedGoogle Scholar
  58. 58.
    Hartmaier SL, Sloane PD, Guess HA, Koch GC. The MDS Cognition Scale: a valid instrument for identifying and staging nursing home residents with dementia using the minimum data set J Am Geriatr Soc 1994; 42:1173–1179.Google Scholar
  59. 59.
    Heiat A, Gross CP, Krumholz HM. Representation of elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002; 162:1682–1688.PubMedGoogle Scholar
  60. 60.
    Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham study. J Am Coll Cardiol 1993; 22(suppl A):6A-13A.PubMedGoogle Scholar
  61. 61.
    Howard PA, Shireman TI, Dhingra A, Ellerbeck EF, Fincham JE. Patterns of ACE inhibitor use in elderly Medicaid patients with heart failure. Am J Geriatr Card 2002; 11:287–294.Google Scholar
  62. 62.
    Hutcheon SD, Gillespie ND, Crombie IK, Struthers AD, McMurdo MET. Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial. Heart 2002; 88:373–377.PubMedGoogle Scholar
  63. 63. Cardiovascular health and services in Ontario: An ICES atlas. Toronto: ICES 1999: 111–122.Google Scholar
  64. 64.
    Incalzi AR, Capparella O, Gemma A, Porcedda P, Raccis G, Sommella L, Carbonin PU. A simple method of recognizing geriatric patients at risk of death and disability. J Am Geriatr Soc 1992; 40:34–38.PubMedGoogle Scholar
  65. 65.
    Inouye SK, Viscoli CM, Horwitz RI, Hurst LD, Tinetti ME. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 1993; 119:474–481.PubMedGoogle Scholar
  66. 66.
    Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. JAMA 1996; 275:852–857.PubMedGoogle Scholar
  67. 67.
    Jafri SM, Ozawa T, Mammen E, Levine TB, Johnson C, Goldstein S. Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J 1993; 14:205–212.PubMedGoogle Scholar
  68. 68.
    Jansen PA, De Vries OO, De Rooy SE, Raymakers JA. Blood pressure reduction after first dose of captopril and perindopril. J Am Geriatr Soc 2001;49:1574–1575.PubMedGoogle Scholar
  69. 69.
    Jarrett PG, Rockwood K, Carver D, Stolee P, Cosway S. Illness presentation in elderly patients. Arch Intern Med 1995; 155:1060–1064.PubMedGoogle Scholar
  70. 70.
    Jelliffe RW, Buell J, Kalaba R. Reduction of digitalis toxicity by computer-assisted glycoside dosage regimens. Ann Intern Med 1972; 77:891–906.PubMedGoogle Scholar
  71. 71.
    Jelliffe RW, Brooker G. A nomogram for digoxin therapy. Am J Med 1974; 57:63–68.PubMedGoogle Scholar
  72. 72.
    Jolobe OM. Evaluation of renal function in elderly heart failure patients in ACE inhibitors. Postgrad Med J 1999; 75:275–277.PubMedGoogle Scholar
  73. 73.
    Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV. Prognosis and determinants of survival in patients with newly hospitalized heart failure. Arch Intern Med 2002; 162:1689–1694.PubMedGoogle Scholar
  74. 74.
    Jong P, Demers C, McKelvie RS, Liu PP. Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials. J Am Coll Cardiol 2002; 39:463–470.PubMedGoogle Scholar
  75. 75.
    Juby A, Tench S, Baker V. The value of the clock drawing test in identifying executive cognitive dysfunction in people with a normal Mini-Mental State Examination score. Can Med Assoc J 2002; 167:859–864.Google Scholar
  76. 76.
    Kitzman DW, Gardin JM, Gottdiener JS, Boineau AA, Aurigemma G, Marino EK, Lyles M, Cushman M, Enright PL. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. Am J Cardiol 2001; 87:413–419.PubMedGoogle Scholar
  77. 77.
    Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, Hennen J. Readmission after hospitalization for congestive heart failure among medicare beneficiaries. Arch Intern Med 1997; 157:99–104.PubMedGoogle Scholar
  78. 78.
    Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Radford MJ. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med 1997; 157:2242–2247.PubMedGoogle Scholar
  79. 79.
    Krumholz HM, Chen Y-T, Wang Y, Vaccarino V, Radford MJ, Horwitz RI. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 2000; 139:72–77.PubMedGoogle Scholar
  80. 80.
    Lechat P for the CIBIS-II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353:9–13.Google Scholar
  81. 81.
    Lee S-C, Park SW, Kim D-K, Lee SH, Hong KP. Iron supplementation inhibits cough associated with ACE inhibitors. Hypertension 2001; 38:166–170.PubMedGoogle Scholar
  82. 82.
    Lely AH, van Enter CH. Large-scale digitoxin intoxication. BMJ 1970;3:737–740.PubMedGoogle Scholar
  83. 83.
    Levenson JW, McCarthy EP, Lynn J, Davis RB, Phillips RS. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000; 48:S101-S109.PubMedGoogle Scholar
  84. 84.
    Large State Peer Review Organization Consortium. Heart failure treatment with angiotensin- converting enzyme inhibitors in hospitalized medicare patients in 10 large states. Arch Intern Med 1997; 157:1103–1108.Google Scholar
  85. 85.
    Luque CA, Vazquez Ortiz M. Treatment of ACE inhibitor-induced cough. Pharmacotherapy 1999; 19:804–810.PubMedGoogle Scholar
  86. 86.
    Maclntyre I, Capewell S, Stewart S, Chalmers JWT, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJV. Evidence of improving prognosis in heart failure. Circulation 2000; 102:1126–1131.Google Scholar
  87. 87.
    Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Due P, Omland T, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161–167.PubMedGoogle Scholar
  88. 88.
    McAllister FA, Lawson FME, Teo KK, Armstrong PW. A systematic review of randomized trials of disease management programs in heart failure. Am J Med 2001; 110:378–384.Google Scholar
  89. 89.
    McDonnell Cooke D, The use of central nervous system manifestations in early detection of digitalis toxicity. Heart Lung 1993; 22:477–481.Google Scholar
  90. 90.
    Mehagnoul-Schipper DJ, Colier WNJM, Hoefhagels WHL, Verheugt FWA, Jansen RWMM. Effects of furosemide versus captopril on postprandial and orthostatic blood pressure and on cerebral oxygenation in patients 70 years of age with heart failure. Am J Cardiol 2002; 90:596–600.PubMedGoogle Scholar
  91. 91.
    Mordasini MR, Krahenbuhl S, Schlienger RG. Appropriateness of digoxin level monitoring. Swiss Med Wkly 2002; 132:506–512.PubMedGoogle Scholar
  92. 92.
    Miura T, Kojima R, Sugiura Y, Mizutani M, Takatsu F, Suzuki Y. Effect of aging on the incidence of digoxin toxicity. Ann Pharmacother 2000; 34:427–432.PubMedGoogle Scholar
  93. 93.
    Moser DK. Heart failure management: optimal health care delivery programs. Annual Review Nursing Research 2000; 18:91–126.Google Scholar
  94. 94.
    Murray SA, Boyd K, Kendall M, Worth A, Benton TF, Clausen H. Dying from lung cancer or cardiac failure: prospective qualitative interview study of patients and their carers in the community. BMJ 2002; 325:929–933.PubMedGoogle Scholar
  95. 95.
    Newman AB, Gottdiener JS, McBurnie MA, Hirsch CH, Kop WJ, Tracy R, Walston JD, Fried LP. Association of subclinical cardiovascular disease with frailty. Journal of Gerontology: Medical Sciences 2001; 56A:M158-M166.Google Scholar
  96. 96.
    O=Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994; 13:S107-S112.Google Scholar
  97. 97.
    Opasich C, Febo O, Riccardi PG, Traversi E, Forni G, Pinna G, Pozzoli M, Riccardi R, Mortara A, Sanarico M, Cobelli F, Tavazzi L. Concomitant factors of decompensation in chronic heart failure. Am J Cardiol 1996; 78:354–357.PubMedGoogle Scholar
  98. 98.
    Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Ryden L, Thygesen K, Uretsky BF. Comparative effects of low and high doses of the angiotensin- converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation 1999; 100:2312–2318.PubMedGoogle Scholar
  99. 99.
    Packer M, Coats AJS, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344:1651–1658.PubMedGoogle Scholar
  100. 100.
    Papaioannou A, Clarke J-A, Campbell G, Bedard M. Assessment of adherence to renal dosing guidelines in long-term care facilities. J Am Geriatr Soc 2000; 48:1470–1473.PubMedGoogle Scholar
  101. 101.
    Passmore AP, Johnston GD. Digoxin toxicity in the aged. Characterising and avoiding the problem. Drugs Aging 1991; 1:364–378.PubMedGoogle Scholar
  102. 102.
    Pfisterer M, Buser P, Osswald S, Allemann U, Amann W, Angehrn W, et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. JAMA 2003; 289:1117–1123.PubMedGoogle Scholar
  103. 103.
    Philbin EF, Andreou C, Rocco TA, Lynch LJ, Baker SL. Patterns of angiotensm-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996; 77:832–838.PubMedGoogle Scholar
  104. 104.
    Philbin EF, Rocco TA. Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function. Am Heart J 1997; 134:188–195.PubMedGoogle Scholar
  105. 105.
    Philbin EF, Rocco TA JR, Lindenmuth NW, Ulrich K, Jenkins PL. Clinical outcomes in heart failure: Report from a community hospital-based registry. Am J Med 1999; 107:549–555.PubMedGoogle Scholar
  106. 106.
    Pitt B, Zannad, F, Remme WJ, Cody R, Castagne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999:341:709–17.PubMedGoogle Scholar
  107. 107.
    Ranz TT, Blumenschein K, Clifton GD. Prevalence and treatment of heart failure in elderly long-term care patients. Am J Health-Syst Pharm 1999;56:1334–1338.PubMedGoogle Scholar
  108. 108.
    Rathore SS, Wang Y, Krumholz HM. Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart Failure, N Engl J Med 2002; 347:1403–1411.PubMedGoogle Scholar
  109. 109.
    Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003; 289; 871–878.PubMedGoogle Scholar
  110. 110.
    Remes J, Miettinen H, Reuanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12:315–321.PubMedGoogle Scholar
  111. 111.
    Resnick NM. Urinary incontinence in the elderly. Med Grand Rounds 1984; 3:281–290.Google Scholar
  112. 112.
    Rich MW. Heart failure in the 21stcentury: a cardiogeriatric syndrome. Journal of Gerontology: Medical Sciences 2001; 65A:M88-M96.Google Scholar
  113. 113.
    Ruths S, Straand J, Nygaard HA, Hodneland F. Drug treatment of heart failure - Do nursing- home patients deserve better? Scand J Prim Care 2000; 18:226–231.Google Scholar
  114. 114.
    Scanlon J, Borson S. Te Mini-Cog: receiver operating characteristics with expert and naive raters. Int J Geriatr Psychiatry 2001; 16:216–222.Google Scholar
  115. 115.
    Senni M, Redfield MM. Congestive heart failure in elderly patients. Mayo Clin Proc 1997; 72:453–460.PubMedGoogle Scholar
  116. 116.
    Senni M, Rodeheffer RJ, Tribouilloy CM, Evans JM, Jacobsen SJ, Bailey KR, Redfield MM. Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Card 1999; 33:164–170.Google Scholar
  117. 117.
    Setaro JF, Zaret BL, Schulman DS, Black HR, Soufer R. Usefulness of verapamil for congestive heart failure associated with abnormal ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990; 66:981–986.PubMedGoogle Scholar
  118. 118.
    Sharpe N, Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet 1998; 352(suppl l):3–7.Google Scholar
  119. 119.
    Slatton ML, Irani WN, Hall SA, Marcoux LG, Page RL, Grayburn PA, Eichhorn EJ. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol 1997; 29:1206–1213.PubMedGoogle Scholar
  120. 120.
    Stewart S, McMurray JJV. Palliative care for heart failure. BMJ 2002; 325:915–916.PubMedGoogle Scholar
  121. 121.
    Stuck AE, Siu AL, Wieland GD, Adams A, Rubenstein LZ. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 1993; 342: 1032–1036.PubMedGoogle Scholar
  122. 122.
    The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients: the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). JAMA 1995; 274:1591–1598.Google Scholar
  123. 123.
    Swedberg K, Pfeffer M, Granger C, Held P. McMurray J, Ohlin G, Olofsson B, Ostergren J, Yusuf S. Candesartan in heart failure - assessment of reduction in mortality and morbidity (CHARM): rationale and design. J Card Failure 1999;276–282.Google Scholar
  124. 124.
    Tarvonen-Schroder S, Roytta M, Kurki T, Rajala T, Sourander L. Clinical features of leukoaraiosis. J Neurol Neurosurg Psychiatry 1996; 46:942–948.Google Scholar
  125. 125.
    Taylor J, Stott DJ. Chronic heart failure and cognitive impairment: co-existence of conditions or true association? Eur J Heart Failure 2002; 4:7–9.Google Scholar
  126. 126.
    Tresch DD. The clinical diagnosis of heart failure in older patients. J Am Geriatr Soc 1997; 45:1128–1133.PubMedGoogle Scholar
  127. 127.
    Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001; 62[suppl 21]: 11–14.PubMedGoogle Scholar
  128. 128. Population Projections of the United States by age, sex, race and Hispanic origin: 1995–2050. Popular Division. Population Projections Branch, U.S. Census Bureau 1996.Google Scholar
  129. 129.
    Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990; 38:1290–1295.PubMedGoogle Scholar
  130. 130.
    Wallen T, Landahl S, Hedner T, Saito Y, Masuda 1, Nakao K. Brain natriuretic peptide in an elderly population. J Intern Med 1997; 242:307–311.PubMedGoogle Scholar
  131. 131.
    Wang R, Mouliswar M, Denman S, Kleban M. Mortality of the institutionalized old-old hospitalized with congestive heart failure. Arch Intern Med 1998; 158:2464–2468.PubMedGoogle Scholar
  132. 132.
    Ward C. The need for palliative care in the management of heart failure. Heart 2002; 87:294–298.PubMedGoogle Scholar
  133. 133.
    Ware JA, Snow E, Luchi JM, Luchi RJ. Effect of digoxin on ejection fraction in elderly patients with congestive heart failure. J Am Geriatr Soc 1984; 32:631–635.PubMedGoogle Scholar
  134. 134.
    Warner JG, Mtzger DC, Kitzman DW, Wesley DJ, Little WC. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Card 1999; 33:1567–1572.Google Scholar
  135. 135.
    Weedle PB, Poston JW, Parish PA. The use of digoxin in 55 residential homes for elderly people. Postgrad Med J 1988; 64:292–296.PubMedGoogle Scholar
  136. 136.
    Weil E, Tu JV. Quality of congestive heart failure treatment at a Canadian teaching hospital. CMAJ 2001; 165:284–287.PubMedGoogle Scholar
  137. 137.
    Welsh JD, Heiser RM, Schooler MP, Brockopp DY, Parshall MB, Cassidy KB, Saleh U. Characteristics and treatment of patients with heart failure in the emergency department. J Emerg Nurs 2002; 28:126–131.PubMedGoogle Scholar
  138. 138.
    Yamada Y, Goto J, Yokota M. Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease. Cardiology 1997; 88:401–407.PubMedGoogle Scholar
  139. 139.
    Yamamoto K, Burnett JC, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28:988- 994.PubMedGoogle Scholar
  140. 140.
    Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin- converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342:145–153.PubMedGoogle Scholar
  141. 141.
    Zuccala G, Cartel C, Manes-Gravina E, Di Niro MG, Cocchi A, Bernabei R. Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 1997; 63:509–512.PubMedGoogle Scholar
  142. 142.
    Zuccala G, Onder G, Pedone C, Carosella L, Pahor M, Bernabei R. Cocchi A. Hypotension and cognitive impairment: selective association in patients with heart failure. Neurology 2001; 57:1986–1992.PubMedGoogle Scholar
  143. 143.
    Zuccala G, Onder G, Pedone C, Cocchi A, Carosella L, Cartel C, Carbonin PU, Bernabei R. Cognitive dysfunction as a major determinant of disability in patients with heart failure: results from a multicentre survey. J Neurol Neurosurg Psychiatry 2001; 70:109–112.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • George A. Heckman
    • 1
  • Robert S. McKelvie
    • 2
  • Irene D. Turpie
    • 1
  1. 1.Department of Medicine, Division of Geriatric MedicineMcMaster UniversityHamilton
  2. 2.Department of Medicine, Division of CardiologyMcMaster UniversityHamilton

Personalised recommendations